Syremis Therapeutics News and Activities

Acquisition, funding and merger involving Syremis Therapeutics.

• Syremis Therapeutics has just announced a $165 Million fundraising (posted on January 8 2026).

View the org chart displaying its 16 main executives

Most searched biographies at Syremis Therapeutics

• Elisabeth Kogan, Chief Executive Officer
• Reid Huber, Director
• Ilan Oren, Chairman of the Board

Create your alert
to follow the executive moves at Syremis Therapeutics.

Syremis Therapeutics has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Syremis Therapeutics

• News Archive - Syremis Therapeutics
• Syremis Therapeutics

Social media about Syremis Therapeutics

• Syremis Therapeutics on Wikipedia, Google News & Yahoo Finance
• Syremis Therapeutics on LinkedIn, X (Twitter) & YouTube